Phathom Pharmaceuticals, Inc. Separation Agreements
2 Contracts & Agreements
- Transition and Separation Agreement and Release of Claims, dated April 5, 2022, by and between the Registrant and Anthony Guzzo (Filed With SEC on August 2, 2022)
- Separation and Release Agreement dated June 4, 2021, between the Registrant and Todd Branning (Filed With SEC on August 10, 2021)
